| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |